pe.onwuka
TL2 · Funchal
Contributes reviews on supplier material. Based in Funchal.
Joined 15 November 2024 · last posted 1d
93 posts, newest first. Showing up to 150.
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #43 · Clinical › Bloodwork · 27 Jul 2026 · 1 like What I would want before treating egfr fluctuation as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #82 · Practice › Dosing & titration · 20 Jul 2026 · 0 likes Post #78 and I disagree about the size of the effect, not about the direction. Writing down the date, the dose and the site each week takes fifteen seconds and is the…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #82 · Meta › Announcements · 13 Jul 2026 · 2 likes On Trust level 3 requirements, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #8 · Practice › Interactions · 9 Jul 2026 · 10 likes Post #5 is right about the mechanism and I think understates the practical bit. Speaking only to Delayed gastric emptying and oral as I have actually seen it, rather…
-
Prescription requirements and telehealth models — a second dataset Replied, post #94 · Sourcing › Regulatory · 6 Jul 2026 · 5 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post. Posted with less…
-
Naming conventions for research peptides and the confusion they cause Replied, post #26 · Compounds › Other compounds · 6 Jul 2026 · 26 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #27 · Evidence › Journal club · 5 Jul 2026 · 32 likes The strongest argument against my own position on SUSTAIN 6, stated as well as I can state it, since nobody else has yet.
-
Prescription portability between countries Replied, post #76 · Access › International · 25 Jun 2026 · 1 like The question underneath prescription portability between countries is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it.…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #82 · Safety › Contraindications · 21 Jun 2026 · 13 likes Where I part company with post #78, and it is a narrow parting. History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis…
-
Packaging that arrived damaged: documenting it properly Replied, post #28 · Sourcing › Logistics · 20 Jun 2026 · 2 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #20 · Pharmacology › Receptor biology · 17 Jun 2026 · 3 likes Mechanistic plausibility has a poor record of predicting clinical outcomes across this whole field. It is a good reason to run the trial and a bad reason to skip it.
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #32 · Pharmacology › Formulation chemistry · 17 Jun 2026 · 31 likes Antioxidants: compounds that prevent oxidation (which damages peptides) are sometimes included. Methionine oxidation is a common degradation pathway and antioxidants…
-
Isotope patterns and why the monoisotopic peak is not the tallest — does this still hold? Started this topic · Analytics › Mass spectrometry · 13 Jun 2026 · 29 likes Isotope patterns and why the monoisotopic peak is not the tallest — does this still hold? — that is the question, and I have not found it answered plainly anywhere I…
-
Injecting into an area that has become firm: why not to Replied, post #38 · Practice › Administration · 9 Jun 2026 · 0 likes Letting a refrigerated preparation come to room temperature before injecting reduces the sting for most people. It is not a stability requirement, it is a comfort one,…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #54 · Compounds › Semaglutide · 7 Jun 2026 · 8 likes Narrowing post #53, because the general version has more than one answer. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and…
-
Reading a trial's population section before its results Replied, post #94 · Evidence › Trials · 6 Jun 2026 · 19 likes Narrowing post #91, because the general version has more than one answer. Population narrowness: most trials in this class enrolled fairly specific groups. Baseline…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #31 · Evidence › Journal club · 31 May 2026 · 22 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Reading a trial's population section before its results Replied, post #71 · Evidence › Trials · 31 May 2026 · 21 likes That is consistent with mine, for whatever one more account is worth.
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #101 · Compounds › Tirzepatide · 29 May 2026 · 5 likes Post #98 is the version of this I will quote in future. One addition. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #30 · Compounds › Tirzepatide · 7 May 2026 · 29 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #107 · Practice › Reconstitution · 4 May 2026 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
A fridge failure and how I assessed the contents afterwards Replied, post #8 · Devices › Cold chain · 23 Apr 2026 · 0 likes Photographing the parcel on arrival, before opening, takes ten seconds and is the difference between a report and a recollection. The strength of my opinion here…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #28 · Devices › Syringes & needles · 13 Apr 2026 · 29 likes Thank you — that answers what I came here to find out.
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #37 · Evidence › Journal club · 12 Apr 2026 · 4 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. Worth checking…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #21 · Practice › Interactions · 5 Apr 2026 · 0 likes The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather…
-
Preprint servers and what screening they do Replied, post #106 · Evidence › Preprints · 28 Mar 2026 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #108 · Lounge › Introductions · 19 Mar 2026 · 0 likes There is: the practice category, and the calculators, both written for exactly that. Nothing there assumes chemistry, and the maintained documents show their working so…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #7 · Evidence › Journal club · 13 Mar 2026 · 5 likes Summarising the SURMOUNT-4 and continuation versus withdrawal thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #6 · Evidence › Journal club · 9 Mar 2026 · 21 likes Indirect comparison came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
MHRA statements, read directly Replied, post #97 · Regional › UK & Ireland · 26 Feb 2026 · 2 likes Post #94 is right about the mechanism and I think understates the practical bit. MHRA statements is one of those subjects where the general answer and the answer for a…
-
Dead volume across syringe and needle combinations Replied, post #76 · Devices › Syringes & needles · 21 Feb 2026 · 26 likes Building on post #74 rather than restating it. The quoted dead-volume figures for common configurations vary between manufacturers and the ordering is stable: fixed…
-
Adolescents: a distinct evidence base — one year on Replied, post #65 · Clinical › Special populations · 16 Feb 2026 · 5 likes The most useful contribution here is usually a citation to whichever published document comes closest, with a plain statement of how far it is from the question. I…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #48 · Data & Tools › Calculators · 15 Feb 2026 · 23 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #22 · Practice › Interactions · 14 Feb 2026 · 2 likes On post #20 — agreed on the reasoning, with one qualification. Where a published interaction study exists it usually reports an area-under-curve ratio, and that number…
-
Reading an interaction checker output critically Replied, post #118 · Practice › Interactions · 12 Feb 2026 · 30 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Cost per delivered dose, which is the number that matters Replied, post #46 · Access › Pricing · 7 Feb 2026 · 32 likes Nothing here is financial advice and none of it is a route to a transaction.
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #56 · Compounds › Semaglutide · 16 Jan 2026 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #15 · Practice › Side effects · 13 Jan 2026 · 0 likes That is a cleaner way of putting what I was circling around.
-
A partial dose because the pen emptied mid-injection Replied, post #20 · Practice › Administration · 7 Jan 2026 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #67 · Practice › Interactions · 12 Dec 2025 · 18 likes Checked the Warfarin and altered intake claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #33 · Pharmacology › Pharmacokinetics · 7 Dec 2025 · 4 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #79 · Practice › Reconstitution · 9 Nov 2025 · 10 likes A request rather than an answer: could whoever has the primary source for Over-dilution post it? I have seen the claim three times this month and each version had lost…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #9 · Sourcing › Regulatory · 30 Oct 2025 · 0 likes The strongest argument against my own position on Pharmaceutical compounding rules, stated as well as I can state it, since nobody else has yet.
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #105 · Analytics › HPLC & UHPLC · 13 Oct 2025 · 0 likes Post #101 and I disagree about the size of the effect, not about the direction. A chromatogram image at a resolution where you can see peak shape but not baseline…
-
New subcategory: rationale and scope Replied, post #11 · Meta › Announcements · 12 Oct 2025 · 20 likes Where the new subcategory reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
What a purity-only report leaves out Replied, post #44 · Sourcing › Independent verification · 12 Oct 2025 · 0 likes Everything in post #42 holds. The case it does not cover is the one I have. I disagree with the framing of purity-only above, and I think it is a substantive…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #5 · Start Here › Welcome · 11 Oct 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #74 · Practice › Reconstitution · 7 Oct 2025 · 2 likes Where I have landed on decimal-point error, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has…
-
Gauge and length selection for subcutaneous injection Replied, post #37 · Devices › Syringes & needles · 7 Oct 2025 · 24 likes Building on post #36 rather than restating it. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer).…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile… Replied, post #4 · Compounds › Semaglutide · 3 Oct 2025 · 1 like Appetite effects and gastrointestinal effects are frequently reported together and are not the same mechanism reported twice. Slowed gastric emptying contributes to…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #44 · Pharmacology › Receptor biology · 25 Sep 2025 · 1 like Narrowing post #42, because the general version has more than one answer. GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion),…
-
Payment method and the leverage it gives you, ranked Replied, post #44 · Sourcing › Payments · 20 Sep 2025 · 17 likes Post #42 describes the usual case. This is about the unusual one. Whatever method is used, the record of what was ordered and what was quoted is the thing that matters…
-
Second pass at: Programming during a large energy deficit Replied, post #6 · Nutrition & Training › Resistance training · 12 Sep 2025 · 0 likes Where I have landed on Programming during a large energy, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #87 · Evidence › Journal club · 8 Sep 2025 · 30 likes That is a cleaner way of putting what I was circling around.
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #22 · Data & Tools › Datasets · 7 Sep 2025 · 0 likes Narrowing post #19, because the general version has more than one answer. Where a value is derived rather than measured, mark it. Derived columns get treated as…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #36 · Practice › Side effects · 16 Aug 2025 · 1 like Dehydration is the mechanism behind more of the secondary complaints here than people expect. Reduced intake plus vomiting plus a warm week is a straightforward path to…
-
Coming back to: When "no data" is the complete and final answer Replied, post #83 · Compounds › Other compounds · 13 Aug 2025 · 11 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Travel coolers and how long they really hold Replied, post #76 · Devices › Cold chain · 7 Aug 2025 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
-
When a preprint is the best available evidence and we say so Replied, post #27 · Evidence › Preprints · 5 Aug 2025 · 0 likes Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry the same weight. I would rather post the uncertainty than round it…
-
A ten-fold dose error caught before injection — one year on Replied, post #6 · Devices › Syringes & needles · 31 Jul 2025 · 12 likes Worth separating ten-fold dose error caught as a question about the compound from ten-fold dose error caught as a question about the documentation. They get answered by…
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #29 · Compounds › Cagrilintide & amylin analogues · 22 Jul 2025 · 16 likes Confirming post #28 from a second method, which matters more than confirming it from a second person. Amylin analogues affect gastric emptying as well, so the mechanism…
-
Cagrilintide molecular characteristics and analytical considerations Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 20 Jul 2025 · 10 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
An emergency department visit, described afterwards Replied, post #41 · Safety › Adverse events · 12 Jul 2025 · 7 likes Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with personal or family history of MTC or multiple endocrine neoplasia type 2.…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #29 · Devices › Syringes & needles · 19 Jun 2025 · 0 likes Post #26 and I disagree about the size of the effect, not about the direction. Agreed on Filter needles, with one qualification that I think matters. The reasoning…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #38 · Evidence › Journal club · 14 Jun 2025 · 0 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Antibiotics and a course of something with delayed emptying Replied, post #63 · Practice › Interactions · 12 Jun 2025 · 28 likes The number people quote for antibiotics is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly uninformative…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #65 · Access › Insurance & coverage · 11 Jun 2025 · 33 likes Small correction to my own earlier position on appeal. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore changes…
-
Half-life, steady state, and accumulation worked through Replied, post #56 · Pharmacology › Pharmacokinetics · 2 Jun 2025 · 0 likes On half-life, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Pre-registering a personal experiment, seriously Replied, post #91 · Research Methods › N-of-1 designs · 2 Jun 2025 · 24 likes Reporting the whole series rather than the interesting segment is the discipline that makes personal data worth reading. Selective reporting is the default without…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #117 · Evidence › Journal club · 15 May 2025 · 15 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. I would not lead a decision with this, but I would…
-
Follow-up: What other technical communities get right that we do not Replied, post #75 · Lounge › Off topic · 22 Apr 2025 · 18 likes Unserious but true: I can now identify a certificate template at a glance and I have no professional use for that skill whatsoever. Two people can read the same figure…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #87 · Evidence › Journal club · 21 Apr 2025 · 5 likes Taking post #85 at face value and following it one step further. If you are new and reading this thread for the answer to STEP 1: the answer is conditional, the…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #62 · Evidence › Journal club · 20 Apr 2025 · 23 likes I have three months of notes on STEP 1 and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite conclusion…
-
Reading order for a first week here, and what to skip until later Replied, post #82 · Start Here › Welcome · 14 Apr 2025 · 11 likes This is the answer, and the reason it is the answer is the more useful part.
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #48 · Sourcing › Vendor reports · 2 Apr 2025 · 25 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #84 · Compounds › Cagrilintide & amylin analogues · 1 Apr 2025 · 4 likes Worth distinguishing the combination product from the two components bought separately and mixed. Those are different pharmaceutical objects and nothing published about…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #67 · Compounds › Cagrilintide & amylin analogues · 30 Mar 2025 · 20 likes Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #95 · Analytics › COA interpretation · 18 Mar 2025 · 2 likes Counter-ion form came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #31 · Practice › Reconstitution · 14 Mar 2025 · 13 likes Saving this. It is the version I will quote when the question comes round again.
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #93 · Data & Tools › Calculators · 16 Feb 2025 · 27 likes Thank you for taking the time. That was more work than a reply usually is.
-
A page that has drifted out of date and needs a maintainer Replied, post #58 · Documentation › Wiki requests · 31 Jan 2025 · 0 likes The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems important. This is where my knowledge stops and I…
-
Why our vendor pages link the storefront and mark it sponsored Replied, post #18 · Sourcing › Vendor reports · 28 Dec 2024 · 7 likes Careful with the language on vendor pages link the storefront. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #127 · Practice › Dosing & titration · 16 Dec 2024 · 5 likes Post #126 is right about the mechanism and I think understates the practical bit. The four-week step is a trial convention, not a pharmacological constant. It is…
-
What we do not know about retatrutide, listed explicitly Replied, post #14 · Compounds › Retatrutide · 7 Dec 2024 · 11 likes Post #10 describes the usual case. This is about the unusual one. Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #86 · Compounds › Repair & healing peptides · 18 Nov 2024 · 27 likes The lyophilised cake is worth looking at before adding diluent. A collapsed or shrunken cake is not a purity finding but it does say something about how the vial was…
-
Time to steady state after a dose increase Replied, post #46 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 14 likes A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model…
-
When "no data" is the complete and final answer Replied, post #3 · Compounds › Other compounds · 12 Oct 2024 · 0 likes Anything sold as a blend is two analytical problems and usually one number. A single purity figure for a two-component preparation does not tell you the ratio, and the…
-
When a red flag was a misunderstanding, and the retraction Replied, post #30 · Sourcing › Red flags · 8 Oct 2024 · 2 likes Post #27 describes the usual case. This is about the unusual one. Inconsistency across documents: a certificate stating one purity, a website claiming another, and a…
-
Blind submission and why it changes minds Replied, post #74 · Sourcing › Independent verification · 29 Sep 2024 · 4 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. Speaking for myself and not for…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #39 · Evidence › Journal club · 10 Sep 2024 · 0 likes On post #37 — agreed on the reasoning, with one qualification. SURPASS-2 is one of those subjects where the general answer and the answer for a specific case diverge,…
-
Gradient steepness and apparent purity: a worked comparison Started this topic · Analytics › HPLC & UHPLC · 8 Jul 2024 · 0 likes On the subject in the title: Gradient steepness and apparent purity: a worked comparison Working notes rather than a conclusion. I have spent a fortnight trying to pin…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #20 · Practice › Dosing & titration · 29 Jun 2024 · 17 likes Post #16 put the caveat in the right place and I want to underline it. Trying to state the four-week escalation interval position in a way that someone who disagrees…
-
Assessing a warm arrival: the decision process — one year on Replied, post #124 · Sourcing › Logistics · 2 Jun 2024 · 1 like The most useful logistics record is boring: order date, dispatch date, arrival date, condition on arrival. Four fields, and they answer most questions here.